Company / SG&A Expense
Xtant Medical Holdings, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$28.7M
FY2025
5-year range
$13.5M / $28.7M
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 4 consecutive years, from $14M in FY2021 to $29M in FY2025.
Based on SEC 10-K filings.
$29M in FY2025 with a 5-year CAGR of +10.6%.
Increased from $15M to $29M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +25.7%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Xtant Medical Holdings, Inc.'s sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +10.6%, indicating consistent growth.
- In FY2025, sg&a expense increased 11.0% year-over-year.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.7M | +11.0% |
| FY2024 | $25.9M | +67.2% |
| FY2023 | $15.5M | +7.0% |
| FY2022 | $14.4M | +7.0% |
| FY2021 | $13.5M | -22.1% |
| FY2020 | $17.3M | +21.5% |
| FY2019 | $14.3M | -6.4% |
| FY2018 | $15.2M | -3.3% |
| FY2017 | $15.8M | +21.3% |
| FY2016 | $13.0M | +46.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026